Virus-host interactions encompass the complex relationship between viruses and their host organisms. These interactions are critical determinants of the outcome of viral infections, influencing factors such as host susceptibility, immune response, and the severity of disease. Upon entering a host, viruses interact with specific host cell receptors, facilitating attachment and entry. The host immune system recognizes and responds to viral infections through intricate signaling pathways, involving the activation of various immune cells and the release of antiviral molecules. Viruses, in turn, employ diverse strategies to evade or modulate host immune responses. This includes the inhibition of host antiviral proteins, interference with cellular signaling, and the ability to establish latent infections. Understanding virus-host interactions is essential for developing therapeutic interventions. Research in this field aims to uncover the molecular mechanisms governing these interactions, identify potential targets for antiviral drugs, and design strategies to modulate host immune responses for better outcomes. Ongoing studies in virology continue to deepen our understanding of virus-host interactions, contributing to the development of effective treatments and vaccines against viral infections.
Title : A promising novel approach to DNA vaccines
Khursheed Nadeem Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data for a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Advances in vaccines: Revolutionizing disease prevention
Delia Teresa Sponza, Dokuz Eylul University, Turkey